Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

GlobeNewsWire

15 Jun 2026, 23:25 UTC · 3h ago

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

What the story claims

2 claims · each scored for market impact

What matters in this story

1
The FDA issued a Complete Response Letter (CRL) refusing to approve Disc Medicine's new drug application for bitopertin due to uncertainties requiring additional evidence. — A CRL is a major setback for biotech companies as it delays or prevents the commercialization of a key product candidate.
-0.80
2
The Rosen Law Firm is investigating potential securities claims and preparing a class action lawsuit against Disc Medicine alleging materially misleading business information. — Legal action and allegations of misleading investors create additional financial liability and reputational risk for the company.
-0.30

Which stocks this story touches

How each ticker is affected

IRON-1.00
The company received an FDA Complete Response Letter rejecting a drug application and is facing a securities class action investigation.

6 related stories

GlobeNewsWire
2h ago
RGC DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
- biotechnology
- class action
- securities litigation
Read

Disc Medicine Investor Ne… — IRON -1.00 | NewsImpactScreener

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

What matters in this story

How each ticker is affected

RGC DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

What matters in this story

How each ticker is affected

RGC DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

U.S. FDA Accepts Gilead's Application for Investigational Once-Weekly Oral Yeztugo, Potentially the First Long-Acting Pill for HIV Prevention

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sportradar Group AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRAD

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Nano-X Imaging Ltd.

ROSEN, A LEADING NATIONAL FIRM, Encourages Lucid Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - LCID

Verra Mobility Corporation (VRRM) Securities Class Action Filed Amid Avis' Termination Notice, CEO Departure, Internal Review of Negotiations & Handling of Confidential Information – Hagens Berman

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

What matters in this story

How each ticker is affected

Next reads from the same story arc

RGC DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

What matters in this story

How each ticker is affected

Next reads from the same story arc

RGC DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

U.S. FDA Accepts Gilead's Application for Investigational Once-Weekly Oral Yeztugo, Potentially the First Long-Acting Pill for HIV Prevention

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sportradar Group AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRAD

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Nano-X Imaging Ltd.

ROSEN, A LEADING NATIONAL FIRM, Encourages Lucid Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - LCID

Verra Mobility Corporation (VRRM) Securities Class Action Filed Amid Avis' Termination Notice, CEO Departure, Internal Review of Negotiations & Handling of Confidential Information – Hagens Berman